Active Ingredient(s): Lumacaftor + Ivacaftor
FDA Approved: * July 2, 2015
Pharm Company: * VERTEX PHARMS INC
Category: Genetic Disorders

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Orkambi Overview

Lumacaftor/ivacaftor, sold under the brand name Orkambi among others, is a combination of lumacaftor and ivacaftor used to treat people with cystic fibrosis who have two copies of the F508del mutation.[3] It is unclear if it is useful in cystic fibrosis due to other causes.[3] It is taken by mouth.[3] Common side effects include shortness of breath, nausea, diarrhea, feeling tired, hearing problems, and rash.[3][4]...

Read more Orkambi Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Lumacaftor/ivacaftor

Recent Orkambi Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Lumacaftor + Ivacaftor
  • Granule: 100mg + 125mg, 125mg/packet + 100mg/packet, 150mg + 188mg, 188mg/packet + 150mg/packet
  • Tablet: 125mg + 100mg, 125mg + 200mg, 200mg/125mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Orkambi: (4 results)

Sorted by National Drug Code
  • 51167-500 Orkambi Oral Granule by Vertex Pharmaceuticals Incorporated
  • 51167-700 Orkambi Oral Tablet, Film Coated by Vertex Pharmaceuticals Incorporated
  • 51167-809 Orkambi Oral Tablet, Film Coated by Vertex Pharmaceuticals Incorporated
  • 51167-900 Orkambi Oral Granule by Vertex Pharmaceuticals Incorporated

Drugs with one or more similar ingredients: (7 results)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 April 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA